Marijuana, Vaping, and Hallucinogens Use Hits All Time High Among Adults 35 to 50: New Study

Older adults are turning to marijuana, alcohol, vaping, and hallucinogens now more than ever before

Dried hallucinogenic magic mushrooms. Smit/Shutterstock

The National Institutes of Health (NIH) released a report (pdf) Thursday showing an alarming number of people engaging in behaviors like smoking marijuana, binge drinking, using hallucinogenic drugs, and vaping has climbed to historic highs.

Marijuana

Results of the comprehensive report, Monitoring the Future (MTF), detailed that marijuana use among 19- to 30-year-olds rose steadily over a 10-year period, rising from about 28 percent in 2012 to a little over 43 percent in 2022.

In adults 35 to 50, the percent increase doubled to about 28 percent over the same 10-year timeframe.

In addition to the annual uptick, daily marijuana use in 19- to 30-year-olds also reached the highest levels ever reported by the study. One in 10 adults use marijuana every day.

Frequent use of marijuana, when used in high doses, can cause disorientation and paranoia. Hallucinations and temporary psychosis are also common in the frequent use of marijuana with high THC content (the active compound in cannabis). Evidence also shows marijuana is tied to depression, social anxiety and suicidal thoughts, suicide attempts, and suicide.

Long-term use can lead to addiction, psychiatric disorders, impaired brain development and function, and syndromes resulting in severe, cyclical nausea and vomiting. It’s also possible marijuana may act as a “gateway drug,” thus increasing the risk of future or concurrent addiction to other substances such as alcohol or nicotine.

But marijuana is just one of the risky behaviors adults in both categories increasingly turn to. Alcohol, vaping, and hallucinogenic drug use are also at their highest, posing a significant public health threat.

Marijuana gummies. Victor Moussa/Shutterstock

Alcohol

Alcohol tops the list for both young and older adults as the most widely used substance, with about 83 percent of 19- to 30-year-olds saying they drank in 2022. Drinking in older adults exceeded the younger generation.

Binge drinking is the most common form of excessive drinking and is defined differently for men and women. For women, binge drinking means consuming four or more drinks during a single occasion. For men, the number is five drinks. Heavy drinking is linked to a host of chronic diseases, including high blood pressure, heart disease, stroke, liver disease, and pancreatic, breast, and prostate cancer.

Vaping

Marijuana vaping was reported by over 21 percent of young people in 2022—an increase from 11.5 percent in 2017 when MFT first started tracking it. Past-year nicotine vaping among this group also hit a historic high in 2022.

Vaping both marijuana and nicotine has remained at consistent levels in the older group.

Vaping may seem like a harmless alternative to smoking. However, studies show the behavior can result in a range of harmful consequences that are bad for overall health. Emerging data link vaping to chronic lung disease, asthma, and heart disease.

Hallucinogens

Hallucinogens are psychedelic drugs that affect a person’s thoughts and emotions by disrupting communication networks in the brain. When a person is under the influence of a hallucinogen, they are said to be “tripping.“ Reactions to a ”bad trip” can include fear, confusion, or panic.

Past-year hallucinogen use among 19- to 30-year-olds was significantly higher than five and 10 years ago. Today, the number stands at 8 percent.

Engaging in the behavior also reached a historic high among 35- to 50-year-olds. About 4 percent surveyed admitted to using hallucinogens, which may include LSD, MDMA, mescaline, peyote, mushrooms and/or psilocybin, and PCP in 2022. This is nearly double what was reported in 2021.

Old glass bottle containing hallucinogeni substance. Sendo Serra/Shutterstock

Other Substances

Researchers also examined trends in cigarette use, sedatives, and nonmedical use of opioid medication. Results showed a 10-year decline for both the younger and older adult groups. Reports of past-year amphetamine use continued a 10-year decrease among 19- to 30-year-olds but increased over the 10-year period among 35- to 50-year-olds.

“The value of surveys such as MTF is to show us how drug use trends evolve over decades and across development—from adolescence through adulthood,” Megan Patrick, who has a doctorate in human development and family studies, is a research professor at the University of Michigan, and the principal investigator of the MTF panel study, said in a news release. “Behaviors and public perception of drug use can shift rapidly, based on drug availability and other factors. It’s important to track this so that public health professionals and communities can be prepared to respond.”

The survey also shows substance use is not limited to teens and young adults.

“These data help us understand how people use drugs across the lifespan,” National Institute on Drug Abuse (NIDA) director Dr. Nora Volkow said in the same news release. “Understanding these trends is a first step, and it is crucial that research continues to illuminate how substance use and related health impacts may change over time.”

The MTF study is funded by the NIDA, part of the NIH, and is conducted by scientists at the University of Michigan’s Institute for Social Research, Ann Arbor. The participant pool exceeds 110,000 people and dates back to 1975. Approximately 28,500 people have been surveyed each year since then.

Results from the 2022 MTF study of substance use behaviors and related attitudes among teens in the United States were released in December 2022, and 2023 results are slated to be published in December 2023.